Incidence and factors associated with cutaneous immune-related adverse events to immune check point inhibitors: An ambispective cohort study

Incidence and factors associated with cutaneous immune-related adverse events to immune check point inhibitors: An ambispective cohort study

BackgroundAlthough immune checkpoint inhibitors (ICIs) have become the frontline treatment option for patients with various advanced cancers due to improved survival, they can be associated with a spectrum of cutaneous immune-related adverse events (cirAEs). However, little is known regarding the oc...

Full description

Bibliographic Details
Main Authors: Athitaya Luangnara, Salin Kiratikanon, Thanika Ketpueak, Thatthan Suksombooncharoen, Chaiyut Charoentum, Busyamas Chewaskulyong, Napatra Tovanabutra, Siri Chiewchanvit, Surapon Nochaiwong, Mati Chuamanochan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
anti-programmed cell death-1
anti-programmed cell death ligand-1
cutaneous immune-related adverse event
cytotoxic T-lymphocyte antigen-4 inhibitors
immune checkpoint inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.965550/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.965550/full

Similar Items